Researchers identify how cells cope with damage caused by cisplatin during chemotherapy treatment, revealing that lesions in the DNA caused by cisplatin lead to stalling of the transcription machine and subsequent removal of the lesion. Medscape Medical News
Dasatinib continues to demonstrate superior efficacy compared with imatinib in patients with newly diagnosed CML. However, survival rates between dasatinib and imatinib are similar. Medscape Medical News
Five-year results show an absolute benefit of 9% for the combination of cetuximab and radiotherapy, compared with radiotherapy alone, in locoregional disease. Medscape Medical News
Developed by a panel of 24 multidisciplinary prostate cancer experts from NCCN Member Institutions, these guidelines are designed to assist with evidence-based decision-making. Medscape Hematology-Oncology
Investigators assessed germline mutations in the BRCA1 and BRCA2 genes and looked for the involvement of these genes in breast tumor development. Breast Cancer Research
